On August 24-25, the 2018 Conference on Tumor and Translational Medicine, hosted by Bioon, will be held at the Good Hope Hotel in Shanghai.This session is based on the understanding of the complexity of tumors.It will invite more than 30 well-known experts and scholars in the field of tumor immunity to exchange and cooperate, jointly promote the medical transformation of tumor heterogeneity research, promote tumor MDT communication and cooperation with third-party medical tests, and guide the new direction of clinical diagnosis and treatment of tumors.The conference will focus on the hot topics such as origin of tumor heterogeneity, the latest advances in cancer evolution research and its technical means and its impact on drug development, targeted therapy, tumor microenvironment, tumor immunotherapy combination therapy, tumor treatment clinical case, tumor third-party medicine for analysis and discussion.
Wuxi Donglin Sci&Tech Development Co.,Ltd produced the relevant Elisa kit for human tumors.It includes Human Tumor Necrosis Factor Alpha (TNFa) ELISA Kit, Human Tumor Necrosis Factor Beta (TNFb) ELISA Kit, Human Tumor Necrosis Factor Ligand Superfamily, Member 13 (TNFSF13) ELISA Kit，Human Tumor Protein p53 (TP53) ELISA Kit and so on.
Donglin strictly selects international raw materials. After receiving each batch of raw materials, the company will conduct trial and error verification to ensure the traceability of each product. After each product is produced, our quality inspection department will conduct three strict QC, 100% to ensure the high quality of each product, and then deliver it to the company’s logistics department.Dldevelop products have obeyed the international ISO9001:2015 and CE certificated. Products are popular in overseas markets.
Send your message to us:
Post time: Aug-24-2018